The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Community Engagement
Lienkie's Lungs TB Awareness Drama: SATVI collaborated with the UCT Drama Department and the Mothertongue Community project in developing "Lienkie se Longe", a drama to raise awareness about TB. The drama was performed at community clinics and...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...


Sunday, 18 November 2018
15 November 2018 LATEST RESEARCH: Commentary WHO Preferred Product Preferences for TB Vaccines

SATVI Director Professor Mark Hatherill has co-authored a commentary titled "WHO preferred product characteristics for new vaccines against tuberculosis" appearing in The Lancet journal.

Publication Date:
Thursday, November 15, 2018 - 11:30
13 November 2018 RESEARCH Can we predict tuberculosis cure? What tools are available?

Associate Professor Tom Scriba has co authored a paper titled "Can we predict tuberculosis cure? What tools are available?" appearing in the European Respiratory Journal of the European Respiratory Society.

Publication Date:
Tuesday, November 13, 2018 - 12:45
LIVE PRESS CONFERENCE: Union World Conference on Lung Health : M72 Vaccine study primary results presented

Watch the press conference during which the primary results from the M72/AS01E candidate vaccine were announced during the Union World Conference on Lung Health. Professor Mark Hatherill, SATVI Director spoke on behalf of SATVI.

Publication Date:
Sunday, October 28, 2018 - 09:30
23 October 2018 SATVI at the Union Conference on Lung Health

View the full list of SATVI speakers at the The Union World Conference on Lung Health held from 24 to 27 October 2018.

Publication Date:
Tuesday, October 23, 2018 - 12:00